Article
Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
Genome medicine - 12 Dec 2022
Yang Chengran, Fagan Anne M, Perrin Richard J, Rhinn Herve, Harari Oscar, Cruchaga Carlos
Abstract excerpt
BACKGROUND: Human proteins are widely used as drug targets. Integration of large-scale protein-level genome-wide association studies (GWAS) and disease-related GWAS has thus connected genetic variation to disease mechanisms via protein. Previous proteome-by-phenome-wide Mendelian randomization (MR) studies have been mainly focused on plasma proteomes. Previous MR studies using the brain proteome only reported...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
